The store will not work correctly when cookies are disabled.
3-(1-(3,3-difluoropropyl)-6-fluoro-1H-indol-3-yl)benzothioamide
ID: ALA4548497
PubChem CID: 132137344
Max Phase: Preclinical
Molecular Formula: C18H15F3N2S
Molecular Weight: 348.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=S)c1cccc(-c2cn(CCC(F)F)c3cc(F)ccc23)c1
Standard InChI: InChI=1S/C18H15F3N2S/c19-13-4-5-14-15(11-2-1-3-12(8-11)18(22)24)10-23(16(14)9-13)7-6-17(20)21/h1-5,8-10,17H,6-7H2,(H2,22,24)
Standard InChI Key: MRPPNUGHKSWBOM-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
5.9418 -6.6943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9406 -7.5139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6487 -7.9228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3584 -7.5134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3555 -6.6907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6469 -6.2855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0617 -6.2795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7709 -6.6854 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6485 -8.7400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0586 -5.4623 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.9896 -9.2165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2419 -9.9938 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3118 -9.2168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0603 -9.9904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6039 -10.5929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3992 -10.4231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6479 -9.6454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1026 -9.0462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7629 -10.6558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9477 -11.0289 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.0967 -11.4017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6177 -12.0638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9515 -12.8097 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.8048 -11.9799 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
3 9 1 0
7 10 2 0
9 11 2 0
11 12 1 0
12 14 1 0
13 9 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
12 19 1 0
16 20 1 0
19 21 1 0
21 22 1 0
22 23 1 0
22 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 348.39 | Molecular Weight (Monoisotopic): 348.0908 | AlogP: 4.74 | #Rotatable Bonds: 5 |
Polar Surface Area: 30.95 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.69 | CX Basic pKa: ┄ | CX LogP: 4.56 | CX LogD: 4.56 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.68 | Np Likeness Score: -1.32 |
References
1. (2017) Ash1l inhibitors and methods of treatment therewith, |